Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EDEM3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RAB29 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SDHC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IER5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELK4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEC31A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SGCB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ENSA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DCAF6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CHRM3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POGK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POLR2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HGF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKRD17 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PAICS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GRSF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UHMK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GAR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2D3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on